Article PDF
References
Strandness, D. W., Priest, R. W., Gibbons, G. E.: Combined clinical and pathologic study of diabetic and nondiabetic peripheral arterial disease. Diabetes13, 336–372 (1964)
Epstein, F. H.: Hyperglycemia. A risk factor in coronary heart disease. Circulation36, 609–619 (1967)
Mainland, D.: The risk of fallacious conclusions from autopsy data on the incidence of disease with applications to heart disease. Am. Heart J.45, 644–654 (1953)
Garcia, M. J., McNamara, P. M., Gordon, T., Kannel, W. B.: Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes23, 105–111 (1974)
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., Dawber, T. R.: Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham Study. Ann. Intern. Med.87, 393–397 (1977)
Keen, H., Jarrett, R. J.: Macroangiopathy — its prevalence in asymptomatic diabetes. Adv. Metab. Disord. [Suppl.]2, 3–9 (1973)
Ostrander, L. D., Francis, T., Hayner, N. S., Kjelsberg, M. O., Epstein, F. H.: The relationship of cardio-vascular disease to hyperglycemia. Ann. Intern. Med.62, 1188–1198 (1965)
Epstein, F. H., Ostrander, L. D., Johnson, B. J., Payne, M. W., Hayner, N. S., Keller, J. B., Francis, T.: Epidemiological studies of cardiovascular disease in a total community -Tecumseh, Michigan. Ann. Intern. Med.62, 1170–1187 (1965)
Pell, S., D'Alonzo, C. A.: Factors associated with long-term survival of diabetes. J. A. M. A.214, 1833–1840 (1970)
Wahlberg, F., Thomasson, B.: Glucose tolerance in ischaemic cardiovascular disease. In: Carbohydrate metabolism and its disorders. Dickens, F., Randle, P. J., Whelen, W. J. (Eds.); pp. 185–198. London: Academic Press 1968
Heinle, R. A., Levy, R. I., Frederickson, D. S., Gorlin, R.: Lipid and carbohydrate abnormalities in patients with angiographically documented coronary artery disease. Am. J. Cardiol.24, 178–186 (1969)
Falsetti, H. L., Schnatz, J. D., Greene, D. G., Bunnell, I. L.: Serum lipids and glucose tolerance in angiographically proved coronary artery disease. Chest58, 111–115 (1970)
Kingsbury, K. J.: The relation between glucose tolerance and atherosclerotic vascular disease. Lancet1966 II, 1374–1379
Sloan, J. M., Mackay, J. S., Sheridan, B.: Glucose tolerance and insulin response in atherosclerosis. Br. Med. J.1970 IV, 586–588
Ingelfinger, J. A., Bennet, P. H., Liebow, I. M., Miller, M.: Coronary heart disease in the Pima Indians. Electrocardiographic findings and postmortem evidence of myocardial infarction in a population with a high prevalence of diabetes mellitus. Diabetes25, 561–565 (1976)
Merimee, T. J.: A follow-up study of vascular disease in growth-hormone-deficient dwarfs with diabetes. N. Engl. J. Med.298, 1217–1222 (1978)
Stout, R. W., Bierman, E. L., Brunzell, J. D.: Atherosclerosis and disorders of lipid metabolism in diabetes. In: Physiological and biochemical basis of diabetes. Vallence-Owen, J. (Ed.), pp. 125–170. Lancaster: M. T. P. 1975
Stearns, S., Schlesinger, M. J., Rudy, A.: Incidence and clinical significance of coronary artery disease in diabetes mellitus. Arch. Intern. Med.80, 463–474 (1947)
Ricketts, H. T.: The problem of degenerative vascular disease in diabetes. Am. J. Med.19, 933–945 (1955)
Bradley, R. F., Bryfogle, J. W.: Survival of diabetic patients after myocardial infarction. Am. J. Med.20, 207–216 (1956)
Breithaupt, D. J., Leckie, R. B.: Diabetes mellitus: a study of the practicability of life insurance. Can. Med. Assoc. J.85, 299–302 (1961)
Liebow, I. M., Hellerstein, H. K., Miller, M.: Arteriosclerotic heart disease in diabetes mellitus. Am. J. Med.18, 438–447 (1955)
Downie, E., Martin, F. I. R.: Vascular disease in juvenile diabetic patients of long duration. Diabetes8, 383–387 (1959)
New, M. I., Roberts, T. N., Bierman, E. L., Reader, G. G.: The significance of blood lipid alterations in diabetes mellitus. Diabetes12, 208–212 (1963)
Reinheimer, W., Bliffen, G., McCoy, J., Wallace, D., Albrink, M. J.: Weight gain, serum lipids and vascular disease in diabetes. Am. J. Clin. Nutr.20, 986–996 (1967)
Pyke, D. A.: Coronary disease and diabetes. Postgrad. Med. J.44, 966–968 (1968)
University Group Diabetes Program: A study of the effects of hypoglycemic agents on the vascular complications of patients with adult-onset diabetes. Diabetes19 [Suppl. 2], 747–830 (1970)
Porte, D., Jr., Bagdade, J.: Human insulin secretion: an integrated approach. Annu. Rev. Med.21, 219–240 (1970)
Bagdade, J. D., Bierman, E. L., Porte, D. Jr.: The significance of basal insulin levels in evaluation of the insulin response to glucose in diabetic and non-diabetic subjects. J. Clin. Invest.46, 1549–1557 (1967)
Pyke, D. A., Please, N. W.: Obesity, parity and diabetes. J. Endocrinol.15, 26–33 (1957)
Goodner, C. J., Porte, D. Jr.: Determinants of basal insulin secretion in man. In: Handbook of physiology, Section 7, Part 1, pp. 597–609. Washington DC: American Physiological Society 1972
Grodsky, G. M.: Production of autoantibodies to insulin in man and rabbits. Diabetes14, 396–403 (1965)
Pearson, M. J., Martin, F. I. R.: The separation of total plasma insulin from binding proteins using gel filtration: its application to the measurement of rate of insulin disappearance. Diabetologia6, 581–585 (1970)
Heding, L. G.: Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia8, 260–266 (1972)
Gennaro, W. D., Van Norman, J. D.: Quantitation of free, total, and antibody-bound insulin in insulin-treated diabetics. Clin. Chem.21, 873–879 (1975)
Nakagawa, S., Nakayama, H., Sasaki, T., Yoshino, K., Yu, Y. Y., Shinozaki, K., Aoki, S., Mashimo, K.: A simple method for the determination of serum free insulin levels in insulin-treated patients. Diabetes22, 590–600 (1973)
Danowski, T. S., Lombardo, Y. B., Mendelsohn, L. V., Corredor, D. G., Morgan, C. R., Sabeh, G.: Insulin patterns prior to and after onset of diabetes. Metabolism18, 731–740 (1969)
Jackson, W. P. U., van Mieghem, W., Keller, P.: Insulin excess as the initial lesion in diabetes. Lancet1972 I, 1040–1043
Reaven, G. M., Olefsky, J., Farquhar, J. W.: Does hyperglycaemia or hyperinsulinaemia characterise the patient with chemical diabetes. Lancet1972 I, 1247–1249
Savage, P. J., Dippe, S. E., Bennett, P. H., Gordon, P., Roth, J., Rushforth, N. B., Miller, M.: Hyperinsulinemia and hypoinsulinemia. Insulin responses to oral carbohydrate over a wide spectrum of glucose tolerance. Diabetes24, 363–368 (1975)
Ostrander, L. D., Neff, B. J., Block, W. D., Francis, T., Epstein, F. H.: Hyperglycemia and hypertriglyceridemia among persons with coronary heart disease. Ann. Intern. Med.67, 34–41 (1967)
Santen, R. J., Willis, P. W., Fajans, S.S.: Atherosclerosis in diabetes mellitus. Arch. Intern. Med.130, 833–843 (1972)
Carlson, L. A., Bottiger, L. E.: Ischaemic heart disease in relation to fasting values of plasma triglycerides and cholesterol. Lancet1972 I, 865–868
Bierman, E. L., Porte, D. Jr., Bagdade, J. D.: Hypertriglyceridemia and glucose intolerance in man. In: Adipose tissue. Jeanrenaud, B., Hepp, D. (Eds.), pp. 209–212. New York: Academic Press 1970
Topping, D. L., Mayes, P. A.: The immediate effects of insulin and fructose on the metabolism of the perfused liver: changes in lipoprotein secretion, fatty acid oxidation and esterification, lipogenesis and carbohydrate metabolism. Biochem. J.126, 295–311 (1972)
Robertson, R. P., Gavareski, D. J., Henderson, J. D., Porte, D., Jr., Bierman, E. L.: Accelerated triglyceride secretion. A metabolic consequence of obesity. J. Clin. Invest.52, 1620–1626 (1973)
Kashyap, L., Magill, F., Rojas, L., Hoffman, M. M.: Insulin and non-esterified fatty acid metabolism in asymptomatic diabetics and atherosclerotic subjects. Can. Med. Assoc. J.102, 1165–1169 (1970)
Peters, N., Hales, C. N.: Plasma insulin concentrations after myocardial infarction. Lancet1965 I, 1144–1145
Nikkila, E. A., Miettinen, T. A., Vesenne, M. R., Pelkonen, R.: Plasma insulin in coronary heart disease. Lancet1965 II, 508–511
Tzagournis, M., Chiles, R., Ryan, J. M., Skillman, T. G.: Interrelationships of hyperinsulinism and hypertriglyceridemia in young patients in coronary heart disease. Circulation38, 1156–1163 (1968)
Malherbe, C., de Gasparo, M., Berthet, P., de Hertogh, R., Hoet, J. J.: The pattern of plasma insulin response to glucose in patients with a previous myocardial infarction — the respective effects of age and disease. Eur. J. Clin. Invest.1, 265–270 (1970)
Gertler, M. M., Leetma, H. E., Saluste, E., Rosenberger, J. L., Guthrie, R. G.: Ischemic heart disease. Insulin, carbohydrate and lipid interrelationships. Circulation46, 103–111 (1972)
Sorge, F., Schwartkopff, W., Neuhaus, G. U.: Insulin response to oral glucose in patients with a previous myocardial infarction and in patients with peripheral vascular disease. Diabetes25, 586–594 (1976)
Welborn, T. A., Breckenridge, A., Rubenstein, A. H., Dollery, C. T., Fraser, T. R.: Serum-insulin in essential hypertension and in peripheral vascular disease. Lancet1966 I, 1336–1337
Gertler, M. M., Leetma, H. E., Saluste, E., Covalt, D. A., Rosenberger, J. L.: Covert diabetes mellitus in ischaemic heart and cerebrovascular disease. Geriatrics27, 105–120 (1972)
Berchtold, P., Bjorntorp, P., Gustafson, A., Lindholm, B., Tiblin, T., Wilhalmsen, L.: Glucose tolerance, plasma insulin and lipids in relation to adipose tissue cellularity in men after myocardial infarction. Acta Med. Scand.191, 35–41 (1972)
Christiansen, I., Deckert, T., Kjerulf, K., Mitgaard, K., Worning, H.: Glucose tolerance, plasma lipids and serum insulin in patients with ischaemic heart disease. Acta Med. Scand.184, 283–287 (1968)
Devlin, J. G., Stephenson, N.: Hyperinsulinism and hypoglycaemia following acute myocardial infarction. Metabolism17, 999–1004 (1968)
Sloan, J. M., Mackay, J. S., Sheridan, B.: The incidence of plasma insulin, blood sugar and serum lipid abnormalities in patients with atherosclerotic disease. Diabetologia7, 431–433 (1971)
Friedman, M., Byers, S. O., Roseman, R. H., Elevitch, F. R.: Coronary-prone individuals (type A behaviour pattern). Some biochemical characteristics. J.A.M.A.212, 1030–1037 (1970)
Rubenstein, A. H., Seftel, H. C., Miller, K., Bersohn, I., Wright, A. D.: Metabolic responses to oral glucose in healthy South African white, Indian, and African subjects. Br. Med. J.1969 I, 748–751
Logan, R. L., Thomson, M., Riemersma, R. A., Oliver, M. F., Olsson, A. G., Rossner, S., Callmer, E., Walldius, G., Kaijser, L., Carlson, L. A., Lockerbie, L., Lutz, W.: Risk factors for ischaemic heart-disease in normal men aged 40 (Edinburgh-Stockholm study). Lancet1978 I, 949–955
Elkeles, R. S., Lowy, C., Wyllie, A. D. H., Young, J. L., Fraser, T. R.: Serum insulin, glucose and lipid levels among mild diabetics in relation to incidence of vascular complications. Lancet1971 I, 880–883
Ghilchik, M. W., Morris, A. S.: Insulin response to glucose in patients with peripheral vascular disease, arteritis, and Raynaud's phenomenon. Lancet1971 II, 1229–1231
Luft, R., Efendic, S., Cerasi, E.: Prediabetes, diabetes and arteriosclerosis. In: Early phases of coronary heart disease. Larsson, T., Ljungstedt, N. (Eds.), pp. 223–232. Stockholm: Nordiska 1973
Duff, G. L., McMillan, G. C.: The effect of alloxan diabetes on experimental atherosclerosis in the rabbit. I. The inhibition of experimental atherosclerosis in alloxan diabetes. II. The effect of alloxan diabetes on the retrogression of experimental cholesterol atherosclerosis. J. Exp. Med.89, 611–630 (1949)
McGill, H. C., Holman, R. L.: The influence of alloxan diabetes on cholesterol atheromatosis in the rabbit. Proc. Soc. Exp. Biol. Med.72, 72–75 (1949)
Duff, G. L., Brechin, J. H., Finkelstein, W. E.: The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit. IV The effect of insulin therapy on the inhibition of atherosclerosis in the alloxan-diabetic rabbit. J. Exp. Med.100, 371–380 (1954)
Cook, D. L., Mills, L.M., Green, O. M.: The mechanism of alloxan protection in experimental atherosclerosis. J. Exp. Med.99, 119–124(1954)
Beveridge, J. M. R., Johnson, S. E.: Studies on diabetic rats: the production of cardiovascular and renal disease in diabetic rats. Br. J. Exp. Pathol.31, 285–293 (1950)
Lehner, N. D. M., Clarkson, T. B., Lofland, H. B.: The effect of insulin deficiency, hypothyroidism, and hypertension on atherosclerosis in the squirrel monkey. Exp. Mol. Pathol.15, 230–244 (1971)
Kalant, N., Teitelbaum, J. I., Cooperberg, A. A., Harland, W. A.: Dietary atherogenesis in alloxan diabetes. J. Lab. Clin. Med.63, 147–157 (1964)
Pierce, F. T.: The relationship of serum lipoproteins to atherosclerosis in the cholesterol-fed alloxanized rabbit. Circulation5, 401–407 (1952)
Kalant, N., Harland, W. A.: The effect of an atherogenic diet on normal and alloxan-diabetic rats. Can. Med. Assoc. J.84, 251–254 (1961)
Wilson, R. B., Martin, J. M., Hartroft, W. S.: Failure of insulin therapy to prevent cardiovascular lesions in diabetic rats fed an atherogenic diet. Diabetes18, 225–231 (1969)
Cruz, A. B., Amatuzio, D. S., Grande, F., Hay, L. J.: Effect of intra-arterial insulin on tissue cholesterol and fatty acids in alloxan-diabetic dogs. Circ. Res.9, 39–43 (1961)
Foster, D. W., Siperstein, M. D.: Effect of diabetes on cholesterol and fatty acid synthesis in the rat aorta. Am. J. Physiol.198, 25–28 (1960)
Wertheimer, H. E., Bentor, V.: Influence of diabetes on carcohydrate metabolism of aortic tissue. Diabetes11, 422–425 (1962)
Mulcahy, P. D., Winegrad, A. I.: Effects of insulin and alloxan diabetes on glucose metabolism in rabbit aortic tissue. Am. J. Physiol.203, 1038–1042 (1962)
Urrutia, G., Beavan, D. W., Cahill, G. F.: Metabolism of glucose-U-C14 in rat aorta in vitro. Metabolism11, 530–534 (1962)
Mahler, R. F.: Diabetes and arterial lipids. Q. J. Med.34, 484–485 (1965)
Gabbay, K. H.: The sorbitol pathway and the complications of diabetes. N. Engl. J. Med.288, 831–836 (1973)
Clements, R. S., Jr., Morrison, A. D., Winegrad, A. I.: Polyol pathway in aorta: regulation by hormones. Science166, 1007–1008 (1969)
Morrison, A. D., Clements, R. S., Winegrad, A. I.: Effects of elevated glucose concentrations on the metabolism of the aortic wall. J. Clin. Invest.51, 3114–3123 (1972)
Whereat, A. E.: Atherosclerosis and metabolic disorder of the arterial wall. Exp. Mol. Pathol.7, 233–247 (1967)
Bierman, E. L., Eisenberg, S., Stein, O., Stein, Y.: Very low density lipoprotein ‘remnant’ particles: uptake by aortic smooth muscle cells in culture. Biochim. Biophys. Acta329, 163–169 (1973)
Kramsch, D. M., Hollander, W.: The interaction of serum and arterial lipoproteins with elastin of the arterial intima and its role in the lipid accumulation in atherosclerotic plaques. J. Clin. Invest.52, 236–247 (1973)
Zilversmit, D. B.: A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceriderich lipoproteins. Circ. Res.33, 633–638 (1973)
Ross, R.: The smooth muscle cell. II Growth of smooth muscle in culture and formation of elastic fibres. J. Cell Biol.50, 172–186 (1971)
Stout, R. W., Bierman, E. L., Ross, R.: The effect of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circ. Res.36, 319–327 (1975)
Ledet, T., Dzoga, K. F., Wissler, R. W.: Growth of rabbit aortic smooth-muscle cells cultured in media containing diabetic and hyperlipemic serum. Diabetes25, 207–215 (1976)
Ledet, T.: Growth of rabbit aortic smooth muscle cells in serum from patients with juvenile diabetes. Acta Pathol. Microbiol. Scand. [A]84, 508–516 (1976)
Ledet, T.: Growth hormone stimulating the growth of arterial medial cells in vitro. Diabetes25, 1011–1017 (1976)
Ross, R., Glomset, J. A., Kariya, B., Harker, L.: A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc. Natl. Acad. Sci. USA71, 1207–1210 (1974)
Ross, R., Glomset, J. A.: Atherosclerosis and the smooth muscle cell. Science180, 1332–1339 (1973)
Vracko, R., Benditt, E. P.: Manifestations of diabetes mellitus — their possible relationships to an underlying cell defect. Am. J. Pathol.75, 204–222 (1974)
Goldstein, S., Littlefield, J. W., Soeldner, J. S.: Diabetes mellitus and aging: diminished plating efficiency of cultured human fibroblasts. Proc. Natl. Acad. Sci. USA64, 155–160 (1969)
Martin, G. M., Sprague, C. A., Epstein, C. J.: Replicative life-span of cultivated human cells. Effects of donor's age, tissue and genotype. Lab. Invest.23, 86–92 (1970)
Goldstein, S., Moerman, E. J., Soeldner, J. S., Gleason, R. E., Barnett, D. M.: Chronologic and physiologic age affect replicative life-span of fibroblasts from diabetic, prediabetic, and normal donors. Science199, 781–782 (1978)
Vracko, R.: Basal lamina layering in diabetes mellitus: evidence for accelerated rate of cell death and cell regeneration. Diabetes23, 94–104 (1974)
Stout, R. W.: Insulin stimulation of cholesterol synthesis by arterial tissue. Lancet1969 II, 467–468
Stout, R. W.: The effect of insulin on the incorporation of (1-14C) sodium acetate into the lipids of the rat aorta. Diabetologia7, 367–372 (1971)
Stout, R. W.: The effect of insulin on the incorporation of D-glucose-U-14C in the lipids of the rat aorta in vivo. Horm. Metab. Res.7, 31–34 (1975)
Stout, R. W., Buchanan, K. D., Vallance-Owen, J.: Arterial lipid metabolism in relation to blood glucose and plasma insulin in rats with streptozotocin-induced diabetes. Diabetologia8, 398–401 (1972)
Orimo, H., Sakurada, T., Ito, H., Okabe, H., Noma, A., Murakami, M.: Lipid metabolism in aorta of rats with streptozotocin-induced diabetes. Artery1, 335 (1975)
Stout, R. W.: Development of vascular lesions in insulintreated animals fed a normal diet. Br. Med. J.1970 III, 685–687
Stout, R. W., Buchanan, K. D., Vallance-Owen, J.: The relationship of arterial disease and glucagon metabolism in insulin-treated chickens. Atherosclerosis18, 153–162 (1973)
Stout, R. W.: The effect of insulin and glucose on sterol synthesis in cultured rat arterial smooth muscle cells. Atherosclerosis27, 271–278 (1977)
Stout, R. W.: Relative insensitivity to glucagon of sterol synthesis in cultured rat aortic smooth muscle cells. Effect of dibutyryl cyclic AMP. Diabetologia15, 323–326 (1978)
Chait, A., Bierman, E. L., Albers, J. J.: Regulatory role of insulin in the degradation of low density lipoprotein by cultured human skin fibroblasts. Biochim. Biophys. Acta529, 292–299 (1978)
Goldstein, J. L., Brown, M. S.: Lipoprotein receptors, cholesterol metabolism, and atherosclerosis. Arch. Pathol. Lab. Med.99, 181–184 (1975)
Stamler, J., Pick, R., Katz, L. N.: Effect of insulin in the induction and regression of atherosclerosis in the chick. Circ. Res.8, 572–576 (1960)
Renold, A. E., Genet, A. E., Stauffacher, W., Jeanrenaud, B.: Laboratory animals with spontaneous diabetes and/or obesity: suggested suitability for the study of spontaneous atherosclerosis. Prog. Biochem. Pharmacol.4, 363–369 (1968)
Stout, R. W., Vallance-Owen, J.: Insulin and atheroma. Lancet1969 I, 1078–1080
Stout, R. W.: The relationship of abnormal circulating insulin levels to atherosclerosis. Atherosclerosis27, 1–13 (1977)
Oakley, W. G., Pyke, D. A., Tattersall, R. B., Watkins, P. J.: Long-term diabetes. Q. J. Med. NS43, 145–156 (1974)
Bierman, E. L.: Hypertriglyceridemia in early diabetes. Adv. Metab. Disord. [Suppl.2], 67–72 (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stout, R.W. Diabetes and atherosclerosis — The role of insulin. Diabetologia 16, 141–150 (1979). https://doi.org/10.1007/BF01219790
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01219790